Patent ID: 7407626

Claim:
A medical test kit, comprising a first plurality of testing compositions including: a glucose testing composition having 9.8-17.3 w/v % sodium citrate, 5.3-10.0 w/v % anhydrous sodium carbonate, 1.5-1.73 w/v % copper sulfate and a remaining quantity of distilled water; a protein testing composition having 9.4-10.5 w/v % salicylic sulfate, 38-50 ml distilled water in 100 ml protein testing composition, 0.5-2.0 w/v % sodium chloride, 1.0-3.0 v/v % anhydrous acetic acid and a remaining quantity of 95% methanol; a blood testing composition having 0.25-1.0 w/v % benzidine, 40-80 ml acetic acid in 100 ml of said blood testing composition, and a remaining quantity of 95% methanol; a calcium testing composition having 1.5-2.0 w/v % oxalic acid, 1.5-2.0 w/v % oxalic amide, 3.2-3.5 v/v % acetic acid and a remaining quantity of distilled water; and a nitrite testing composition having 0.35-0.45 w/v % sulfanilic acid, 0.2-0.3 w/v % α-naphthyl amide, 1.0-2.0 v/v % methanol, 20-40.0 v/v % acetic acid and a remaining quantity of distilled water; and a first corresponding plurality of interpretation spectra with respect to said glucose testing composition, said protein testing composition, said blood testing composition, said calcium testing composition and said nitrite testing composition respectively, wherein each said testing composition in response to a testing sample reacts to the testing sample for providing a result interpreted by said corresponding interpretation spectrum such that a user is capable of comparing the result and said corresponding spectrum to generate first health condition data.